🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks PeerView for a great talk this morning by Dr. O’Malley, Bhavana Pothuri and Dr. Moore on PARPi, IO, and ADCs in ovarian cancer. Loved the thought provoking clinical cases on sequencing SGO #SGOMtg #SGO2025

So proud of my cofellow Dr. Jess Velasquez on talking about disparities in social media content for cervical cancer patients at #Hashtag this 2.0 forum! #SGO2025 #SGOMtg The James Shannon Westin, MD, MPH, FASCO Gregg Nelson

Spice up your life 🎤🌶️ SGO edition The James MoPOP #SGOMtg #SGO2025

🚨Hot off the press 🗞️ Check out our article on contemporary practice patterns of somatic testing for endometrial cancer at the link below ⬇️ Thanks @GynOncJnls for publishing our commentary! Casey Cosgrove The James SGO sciencedirect.com/science/articl…

Thanks for sharing our study @GynOncJnls !!

🎤 Check out my interview with Dr. @DaniGlassman, a #GynOncology fellow at The James 🏅 She is the recipient of the 2025 FdtnForWomensCancer FWC #Move4Her Research Grant 🧬 Watch as she talks about her research on #EndometrialCancer with a focus on the high-risk MMR-deficient

#ASCO25 abstract accepted! Excited to share more on 2 v. 4 protein panel dMMR test for endometrial cancer! ASCO Casey Cosgrove The James David Cohn, MD, MBA Laura Chambers David OMalley

NIH guts its first and largest study centered on women | Science | AAAS science.org/content/articl… We must continue to speak up against the dismantling of our scientific programs. I am a scientist - I personally care for people with gynecologic cancer but I care about improving the

Presented at #AACR25: Neoadjuvant PD-1 blockade with dostarlimab led to organ preservation in a high proportion of patients with early-stage mismatch repair–deficient tumors, with no compromise of surgical options. Full study results: nej.md/3EsWcoi  AACR

Great day for a PR at the Capital City Half !🏅1:44:19 ⏱️couldn’t have asked for a better running buddy

Assessing preventive gynecologic decisions in individuals with Lynch syndrome SGO IGCS ESGO ASCO OncoAlert sciencedirect.com/science/articl…

AJOG Expert Review: Best Practices for Reducing Pain Associated with Intrauterine Device Placement ow.ly/BKwc50UT8je

A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival: “For every 16 people, exercise prevents 1 person from recurrent/new cancer” “For every 14 people, exercise prevents 1 person from dying”

#ASCO25 Gyn Cancer Orals Underway! First up: TRUST This was primary cytoreduction vs NACT and iCRS done by high volume, highly skilled surgeons. Primary endpoint of OS in ITT was NOT met. Large subgroup of stage III suggests benefit. Those with complete cytoreduction also

🙌ROSELLA ! Overall survival benefit (👍PFS benefit too) with the addition of relacorilant (glucocorticoid antagonist) to nab-paclitaxel in platinum resistant #ovariancancer 🎉🔥Another big win for our patients!!! #ASCO25 #gyncsm

Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but rather the body’s circadian rhythm and physiology: 1: Exercise after surgery 2: Checkpoint inhibitors in the morning

Each year, 420 000+ cases of #UterineCancer are diagnosed worldwide—and that number is set to rise 50% by 2044. It’s the most common gyn cancer in high-income countries and rates are climbing everywhere. This June, raise awareness. Learn more: igcs.org/ucam #Jump4June

So cool seeing exercise in a RCT with improved DFS and OS!

wow. this means so much to me truly….french open champion🥹 i worked so hard for this moment and for it to have happened is insane. thank you God ❤️ and thank you everyone. this means the world…. I ‘m still in shock honestly can’t find the words but all I can say for now is